These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17124163)

  • 1. Paraoxonase 1, 2 and 3 DNA variants and susceptibility to childhood inflammatory bowel disease.
    Sanchez R; Levy E; Seidman E; Amre D; Costea F; Sinnett D
    Gut; 2006 Dec; 55(12):1820-1. PubMed ID: 17124163
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidemiology, genes and inflammatory bowel diseases in childhood.
    de Mesquita MB; Civitelli F; Levine A
    Dig Liver Dis; 2008 Jan; 40(1):3-11. PubMed ID: 17997369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase genes and susceptibility to ALS.
    Greenberg DA; Stewart WC; Rowland LP
    Neurology; 2009 Jul; 73(1):11-2. PubMed ID: 19439719
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to letter to the editor: Paraoxonase genes and the susceptibility to ischemic stroke.
    Liu H
    Int J Stroke; 2014 Apr; 9(3):E7. PubMed ID: 24636586
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of long-term exposure to pesticides on plasma esterases from plastic greenhouse workers.
    Hernández A; Gómez MA; Pena G; Gil F; Rodrigo L; Villanueva E; Pla A
    J Toxicol Environ Health A; 2004 Jul; 67(14):1095-108. PubMed ID: 15205026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of human paraoxonase 1 gene (PON1) and susceptibility to diabetic nephropathy in type I diabetes mellitus.
    Araki S; Makita Y; Canani L; Ng D; Warram JH; Krolewski AS
    Diabetologia; 2000 Dec; 43(12):1540-3. PubMed ID: 11151764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory bowel disease. I. Genetic epidemiology.
    Yang H; Taylor KD; Rotter JI
    Mol Genet Metab; 2001; 74(1-2):1-21. PubMed ID: 11592800
    [No Abstract]   [Full Text] [Related]  

  • 8. [The genetic basis of inflammatory bowel disease unravelled by genetic association studies].
    Visschedijk MC; Festen EA; Wijmenga C; Weersma RK
    Ned Tijdschr Geneeskd; 2009; 153():A402. PubMed ID: 19900309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory bowel disease. II. Gene mapping.
    Taylor KD; Yang H; Rotter JI
    Mol Genet Metab; 2001; 74(1-2):22-44. PubMed ID: 11592801
    [No Abstract]   [Full Text] [Related]  

  • 10. [Genome research on susceptibility loci in inflammatory bowel disease].
    Zheng CQ; Hu GZ
    Zhonghua Nei Ke Za Zhi; 2003 Sep; 42(9):660-2. PubMed ID: 14738050
    [No Abstract]   [Full Text] [Related]  

  • 11. Advances and perspectives in the genetics of inflammatory bowel diseases.
    Chamaillard M; Iacob R; Desreumaux P; Colombel JF
    Clin Gastroenterol Hepatol; 2006 Feb; 4(2):143-51. PubMed ID: 16469672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying susceptibility to inflammatory bowel diseases: a candidate gene approach, genome-wide association studies, or both?
    Pavli P; Summers KM
    J Gastroenterol Hepatol; 2008 Jan; 23(1):6-7. PubMed ID: 18171338
    [No Abstract]   [Full Text] [Related]  

  • 13. Mapping susceptibility loci in inflammatory bowel disease: why and how?
    Parkes M; Satsangi J; Jewell D
    Mol Med Today; 1997 Dec; 3(12):546-53. PubMed ID: 9449126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS.
    Wills AM; Landers JE; Zhang H; Richter RJ; Caraganis AJ; Cudkowicz ME; Furlong CE; Brown RH
    Neurology; 2008 Mar; 70(12):929-34. PubMed ID: 18347314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replication of an association between IL23R gene polymorphism with inflammatory bowel disease.
    Oliver J; Rueda B; López-Nevot MA; Gómez-García M; Martín J
    Clin Gastroenterol Hepatol; 2007 Aug; 5(8):977-81, 981.e1-2. PubMed ID: 17678845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype/phenotype correlations and implications for clinical practice.
    Silverberg MS
    J Pediatr Gastroenterol Nutr; 2008 Apr; 46 Suppl 1():E4-5. PubMed ID: 18354327
    [No Abstract]   [Full Text] [Related]  

  • 17. DLG5 variants and susceptibility to inflammatory bowel disease in the Scottish population.
    Browning BL
    Gut; 2006 Jul; 55(7):1050; author reply 1050. PubMed ID: 16766759
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased DNA oxidative susceptibility without increased plasma LDL oxidizability in Type II diabetes: effects of alpha-tocopherol supplementation.
    Sampson MJ; Astley S; Richardson T; Willis G; Davies IR; Hughes DA; Southon S
    Clin Sci (Lond); 2001 Sep; 101(3):235-41. PubMed ID: 11524040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interrelationship between sex, susceptibility factors, and outcome in ankylosing spondylitis and its associated disorders including inflammatory bowel disease, psoriasis, and iritis.
    Brophy S; Taylor G; Blake D; Calin A
    J Rheumatol; 2003 Sep; 30(9):2054-8. PubMed ID: 12966615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetics of inflammatory bowel disease].
    Zouiten ML; Khalfaoui T; Boubaker J; Chaabouni H; Filali A; Mechmeche R
    Tunis Med; 2004 Jul; 82(7):635-41. PubMed ID: 15552020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.